Wuhan Keqian Biology Co Ltd Working Capital to Net Assets Ratio
Wuhan Keqian Biology Co Ltd working capital to net assets ratio. Wuhan Keqian Biology Co Ltd (688526) has a Working Capital to Net Assets ratio of 51.0% as of September 2025. Working capital of CN¥2.13 Billion (current assets of CN¥2.62 Billion minus current liabilities of CN¥495.11 Million) is measured against net assets of CN¥4.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Wuhan Keqian Biology Co Ltd's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Wuhan Keqian Biology Co Ltd (2016–2024)
Working capital to net assets ratio of Wuhan Keqian Biology Co Ltd from 2016 to 2024. This chart shows how Wuhan Keqian Biology Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 51.0%, reflecting working capital of CN¥2.13 Billion against net assets of CN¥4.17 Billion CNY. See Wuhan Keqian Biology Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Wuhan Keqian Biology Co Ltd Working Capital to Net Assets Ratio by Year (2016–2024)
Wuhan Keqian Biology Co Ltd working capital to net assets ratio by year from 2016 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Wuhan Keqian Biology Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Wuhan Keqian Biology Co Ltd balance sheet assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 51.0% | CN¥2.01 Billion | CN¥3.94 Billion | CN¥2.47 Billion | CN¥463.50 Million | ▲ +3.9 pp |
| 2023 | 47.1% | CN¥1.81 Billion | CN¥3.84 Billion | CN¥2.57 Billion | CN¥758.25 Million | ▼ -8.3 pp |
| 2022 | 55.4% | CN¥1.94 Billion | CN¥3.50 Billion | CN¥2.56 Billion | CN¥623.84 Million | ▲ +15.1 pp |
| 2021 | 40.2% | CN¥1.27 Billion | CN¥3.15 Billion | CN¥1.76 Billion | CN¥492.24 Million | ▼ -37.6 pp |
| 2020 | 77.8% | CN¥2.11 Billion | CN¥2.71 Billion | CN¥2.46 Billion | CN¥354.18 Million | ▲ +20.2 pp |
| 2019 | 57.6% | CN¥645.01 Million | CN¥1.12 Billion | CN¥852.31 Million | CN¥207.31 Million | ▼ -9.0 pp |
| 2018 | 66.6% | CN¥584.02 Million | CN¥876.34 Million | CN¥893.65 Million | CN¥309.64 Million | ▲ +7.9 pp |
| 2017 | 58.7% | CN¥395.38 Million | CN¥673.41 Million | CN¥613.43 Million | CN¥218.04 Million | ▲ +0.1 pp |
| 2016 | 58.6% | CN¥242.00 Million | CN¥413.10 Million | CN¥383.77 Million | CN¥141.76 Million | — |